期刊文献+

1006例创伤感染患者伤口1257株细菌耐药监测 被引量:15

Surveillance of bacterial antibiotic resistance in traumatic wound infection: a report of 1006 cases
原文传递
导出
摘要 目的监测创伤感染患者伤口致病菌分布及时抗生素的敏感性,为临床合理应用抗生素提供依据。方法细菌鉴定采用表型鉴定,极少数菌采用分子生物学鉴定。药敏试验采用最小抑菌浓度(mininmm inhibitory concentration,MIC)微量稀释法或Kirby—Bauer纸片扩散法。结果1006例患者共检出121种1257株致病菌,前10位菌占70.09%。革兰阳性球菌占48.93%,革兰阴性杆菌占49.72%。在金黄色葡萄球菌和表皮葡萄球菌中耐甲氧西林的菌株分别占34.76%和71.08%;未检出对万古霉素、利奈唑胺耐药的金黄色葡萄球菌和表皮葡萄球菌。在粪肠球菌中耐万古霉素肠球菌(vancomycin resistantent erococcal,VRE)检出率为6.06%,敏感率〉90%的抗生素依次为替考拉宁、氨苄青霉素及万古霉素。在屎肠球菌中VRE检出率为10.53%,替考拉宁敏感率〉90%,万古霉素敏感率〉80%。多重耐药鲍曼不动杆菌检出率为12.77%,敏感率〉70%的依次为亚胺培南、美罗培南。多重耐药鲍曼醋酸钙复合不动杆菌检出率为29.72%,敏感率〉50%的依次为亚胺培南、美罗培南。多重耐药铜绿假单胞菌检出率为3.73%,敏感率〉90%的依次为阿米卡星、美罗培南、亚胺培南及哌拉西林/他唑巴坦。未检出耐亚胺培南、美罗培南的大肠埃希菌、肺炎克雷伯菌和阴沟肠杆菌。大肠埃希菌中产超广谱β-内酰胺酶(extended-spectrum β-lactamases,ESBLs)菌株检出率为69.51%,哌拉西林/他唑巴坦敏感率〉90%,阿米卡星敏感率〉80%。肺炎克雷伯菌中产ESBLs株检出率为53.13%,阿米卡星敏感率〉80%。结论创伤感染以常见菌为主,粪肠球菌和屎肠球菌均对替考拉宁敏感性最高;两种不动杆菌均对亚胺培南具有最高敏感性。 Objective To monitor the distribution of pathogenic bacteria causing wound infection in trauma patients and their susceptibility to antibiotics in an effort to offer evidence for the rational clini- cal use of antibiotics. Methods Pathogens were identified by expressive type, but a very few was de- temlined by the molecular methods. Micro-dilution or Kirby-Bauer inethod for minimum inhibitory concen- tration (MIC) was adopted for drug susceptibility test. Results A total of 121 species of pathogens numbering 1,257 bacterial strains were isolated from 1,066 patients. Strain number of the top 10 species accounted for 70. 09%. Gram-positive cocci accounted for 48. 93% and Gram-negative bacilli for 49.72%. Among Staphylococcus aureus and epidermidis, methicillin-resistant bacterial strains accounted for 34.76% and 71.08% respectively, but none were resistant to vancomycin or linezolid. Enterococcus faecalis contained 6.06% vancomycin-resistant enterococcal (VRE) and remained 〉90% sensitive to teicoplanin, ampicilin and vancomycin. Enterococcus faecium contained 10.53% VRE and remained 〉 90% sensitive to teicoplanin and 〉 80% sensitive to vancomycin. Baumanii contained 12.77% multi- drug resistant strains and remained 〉70% sensitive to imipenem and meropenem. Baumanii/calcoacetic- us complex contained 29.72% multi-drug resistant strains and remained 〉 50% sensitive to imipenem and meropenem. Pseudomonas aeruginosa contained 3.73% multi-drug resistant strains and remained 〉 90% sensitive to amikacin, meropenem, imipenem and piperacillin/tazobactam. No E. coli, klebsiellapneumoniae and enterobacter cloacae resistant to imipenem or meropenem were found. E. coli contained 69.51% extended-spectrum β-1actamases (ESBLs) -producing strains and remained 〉 90% sensitive to piperacillin/tazobactam and 〉 80% sensitive to amikacin. Klebsiella pneumoniae contained 53.13% ES- BLs -producing strains and remained 〉 80% sensitive to amikacin. Conclusions Common bacteria are the leading cause of posttraumatic infection. Enterococcus faecalis and enterococcus faecium demonstrate higher susceptibility to teicoplanin; two kinds of acinetobacter demonstrate higher susceptibility to imipen- era.
出处 《中华创伤杂志》 CAS CSCD 北大核心 2013年第11期1094-1098,共5页 Chinese Journal of Trauma
关键词 感染 创伤和损伤 抗药性 细菌 Infection Wounds and injuries Drug resistance, bacteria
  • 相关文献

参考文献8

二级参考文献48

  • 1李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 2李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:224
  • 3Biedenbach D J, Bell JM, Sader HS, et al. Antimicrobial susceptibility of Gram - positive bacterial isolates from the Asia - Pacific region and in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004) [J]. Int J Antimicrob Agents, 2007; 30:143 - 149.
  • 4Turmer PJ. MYSTIC Europe 2007 : Activity of meropenem and other broadspectrum agents against nosocomial isolates [ J ]. Diagn Microbiol Infect Dis, 2009; 63:217-222.
  • 5Jones RN, Kirby JT, Rhomberg PR. Comparative activity of meropenem in US medical centers (2007) : Initiating the 2nd decade of MYSTIC program surveillance [ J ]. Diagn Microbiol Infect Dis, 2008; 61 : 203 -213.
  • 6Oteo J, Cuevas O, Navarre C, et al. Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001 -06, Spain) : Increasing ampicillin resistance in Enterococcus faecium [ J ]. J Antimicrob Chemother, 2007 ; 21 : 1044 - 1045.
  • 7Bouchillon SK, Iredell JR, Barkham T, et al. Comparative in vitro activity of tigecycline and other antimicrobials against Gram - negative and Gram - positive organisms collected from the Asia - Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST) [J]. Int J Antimicrob Agents,2009; 33:130 -136.
  • 8Inoue M, Farrell D J, Kaneko K, et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1 - 5 ( 1999 - 2004) [ J ]. Microb Drug Resist, 2008 ; 14 : 109 - 117.
  • 9Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20, 2010.
  • 10Nakamura T,Shimizu C,Kasahara M,et al. Differences in antimicrobial susceptibility breakpoints for Pseudomonas aeruginosa,isolated from blood cultures,set by the Clinical and Laboratory Standards Institute (CLSI) and the Japanese Society of Chemotherapy.J Infect Chemother,2007,13:24-29.

共引文献223

同被引文献147

引证文献15

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部